Abstract
Background
Pulmonary morbidities after esophagectomy are still common and are a major cause of surgery-related mortality. The relationship between minimally invasive esophagectomy (MIE) and pulmonary morbidities is not clear. The current study aimed to examine the incidence of pulmonary morbidities after MIE and to clarify the associated risk factors.
Methods
Between May 2011 and December 2016, 184 patients underwent MIE for esophageal cancer. Clinical data were prospectively collected and analyzed. Patient- and surgery-related factors, relating to pulmonary complications, were compared between the complicated and uncomplicated cases.
Results
The incidence of any pulmonary morbidity following MIE was 17.9%. Univariate analysis showed that past heavy smoking [Brinkman index (BI) ≥ 1000], presence of neoadjuvant therapy, advanced clinical stage (stage III, IV), and intraoperative bleeding ≥ 600 g were candidates for being postoperative pulmonary morbidity risk factors. Multivariate analysis suggested that BI ≥ 1000 and advanced clinical stage were independent risk factors for causing pulmonary morbidities.
Conclusions
Past heavy smoking and advanced stage are independent risk factors for pulmonary morbidities after MIE. When performing MIE for such cases, various preoperative precautions and careful postoperative monitoring are necessary.
Similar content being viewed by others
References
Maas KW, Biere SS, van Hoogstraten IM, van der Peet DL, Cuesta MA (2014) Immunological changes after minimally invasive or conventional esophageal resection for cancer: a randomized trial. World J Surg 38(1):131–137. https://doi.org/10.1007/s00268-013-2233-0
Masuda M, Okumura M, Doki Y, Endo S, Hirata Y, Kobayashi J, Kuwano H, Motomura N, Nishida H, Saiki Y, Saito A, Shimizu H, Tanaka F, Tanemoto K, Toh Y, Tsukihara H, Wakui S, Yokomise H (2016) Thoracic and cardiovascular surgery in Japan during 2014: annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 64(11):665–697. https://doi.org/10.1007/s11748-016-0695-3
Takeuchi H, Miyata H, Gotoh M, Kitagawa Y, Baba H, Kimura W, Tomita N, Nakagoe T, Shimada M, Sugihara K, Mori M (2014) A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg 260(2):259–266. https://doi.org/10.1097/sla.0000000000000644
Mamidanna R, Bottle A, Aylin P, Faiz O, Hanna GB (2012) Short-term outcomes following open versus minimally invasive esophagectomy for cancer in England: a population-based national study. Ann Surg 255(2):197–203. https://doi.org/10.1097/SLA.0b013e31823e39fa
Kataoka K, Takeuchi H, Mizusawa J, Ando M, Tsubosa Y, Koyanagi K, Daiko H, Matsuda S, Nakamura K, Kato K, Kitagawa Y (2016) A randomized Phase III trial of thoracoscopic versus open esophagectomy for thoracic esophageal cancer: Japan Clinical Oncology Group Study JCOG1409. Jpn J Clin Oncol 46(2):174–177. https://doi.org/10.1093/jjco/hyv178
Mu J, Gao S, Mao Y, Xue Q, Yuan Z, Li N, Su K, Yang K, Lv F, Qiu B, Liu D, Chen K, Li H, Yan T, Han Y, Du M, Xu R, Wen Z, Wang W, Shi M, Xu Q, Xu S, He J (2015) Open three-stage transthoracic oesophagectomy versus minimally invasive thoraco-laparoscopic oesophagectomy for oesophageal cancer: protocol for a multicentre prospective, open and parallel, randomised controlled trial. BMJ Open 5(11):e008328. https://doi.org/10.1136/bmjopen-2015-008328
Briez N, Piessen G, Bonnetain F, Brigand C, Carrere N, Collet D, Doddoli C, Flamein R, Mabrut JY, Meunier B, Msika S, Perniceni T, Peschaud F, Prudhomme M, Triboulet JP, Mariette C (2011) Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial—the MIRO trial. BMC Cancer 11:310. https://doi.org/10.1186/1471-2407-11-310
Zingg U, Smithers BM, Gotley DC, Smith G, Aly A, Clough A, Esterman AJ, Jamieson GG, Watson DI (2011) Factors associated with postoperative pulmonary morbidity after esophagectomy for cancer. Ann Surg Oncol 18(5):1460–1468. https://doi.org/10.1245/s10434-010-1474-5
Baba Y, Yoshida N, Shigaki H, Iwatsuki M, Miyamoto Y, Sakamoto Y, Watanabe M, Baba H (2016) Prognostic impact of postoperative complications in 502 patients with surgically resected esophageal squamous cell carcinoma: a retrospective single-institution study. Ann Surg Oncol 264(2):305–311. https://doi.org/10.1097/sla.0000000000001510
Saeki H, Tsutsumi S, Tajiri H, Yukaya T, Tsutsumi R, Nishimura S, Nakaji Y, Kudou K, Akiyama S, Kasagi Y, Nakanishi R, Nakashima Y, Sugiyama M, Ohgaki K, Sonoda H, Oki E, Maehara Y (2017) Prognostic significance of postoperative complications after curative resection for patients with esophageal squamous cell carcinoma. Ann Surg 265(3):527–533. https://doi.org/10.1097/sla.0000000000001692
Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2010) AJCC cancer staging manual, 7th edn. Springer, New York
Shiozaki A, Fujiwara H, Okamura H, Murayama Y, Komatsu S, Kuriu Y, Ikoma H, Nakanishi M, Ichikawa D, Okamoto K, Ochiai T, Kokuba Y, Otsuji E (2012) Risk factors for postoperative respiratory complications following esophageal cancer resection. Oncol Lett 3(4):907–912. https://doi.org/10.3892/ol.2012.589
Yoshida N, Watanabe M, Baba Y, Ishimoto T, Iwagami S, Sakamoto Y, Miyamoto Y, Karashima R, Baba H (2014) Influence of preoperative docetaxel, cisplatin, and 5-fluorouracil on the incidence of complications after esophagectomy for resectable advanced esophageal cancer. Dis Esophagus 27(4):374–379. https://doi.org/10.1111/dote.12117
Kuwano H, Nishimura Y, Oyama T, Kato H, Kitagawa Y, Kusano M, Shimada H, Takiuchi H, Toh Y, Doki Y, Naomoto Y, Matsubara H, Miyazaki T, Muto M, Yanagisawa A (2015) Guidelines for diagnosis and treatment of carcinoma of the esophagus april 2012 edited by the Japan Esophageal Society. Esophagus 12:1–30. https://doi.org/10.1007/s10388-014-0465-1
National Cancer Institute (2010) Common terminology criteria for adverse events (CTCAE). United States Department of Health and Human Services, Bethesda
Wilhelm F, Simon E, Boger C, Behrens HM, Kruger S, Rocken C (2017) Novel insights into gastric cancer: methylation of R-spondins and regulation of LGR5 by SP1. Mol Cancer Res 15(6):776–785. https://doi.org/10.1158/1541-7786.MCR-16-0472
Paul DJ, Jamieson GG, Watson DI, Devitt PG, Game PA (2011) Perioperative risk analysis for acute respiratory distress syndrome after elective oesophagectomy. ANZ J Surg 81(10):700–706
Ferguson MK, Celauro AD, Prachand V (2011) Prediction of major pulmonary complications after esophagectomy. Ann Thoracic Surg 91(5):1494–1500. https://doi.org/10.1016/j.athoracsur.2010.12.036 (discussion 1500–1491)
Schieman C, Wigle DA, Deschamps C, Nichols Iii FC, Cassivi SD, Shen KR, Allen MS (2012) Patterns of operative mortality following esophagectomy. Dis Esophagus 25(7):645–651. https://doi.org/10.1111/j.1442-2050.2011.01304.x
Morita M, Nakanoko T, Fujinaka Y, Kubo N, Yamashita N, Yoshinaga K, Saeki H, Emi Y, Kakeji Y, Shirabe K, Maehara Y (2011) In-hospital mortality after a surgical resection for esophageal cancer: analyses of the associated factors and historical changes. Ann Surg Oncol 18(6):1757–1765. https://doi.org/10.1245/s10434-010-1502-5
Biere SS, van Berge Henegouwen MI, Maas KW, Bonavina L, Rosman C, Garcia JR, Gisbertz SS, Klinkenbijl JH, Hollmann MW, de Lange ES, Bonjer HJ, van der Peet DL, Cuesta MA (2012) Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet 379(9829):1887–1892. https://doi.org/10.1016/s0140-6736(12)60516-9
Yibulayin W, Abulizi S, Lv H, Sun W (2016) Minimally invasive oesophagectomy versus open esophagectomy for resectable esophageal cancer: a meta-analysis. World J Surg Oncol 14(1):304. https://doi.org/10.1186/s12957-016-1062-7
Zhou C, Zhang L, Wang H, Ma X, Shi B, Chen W, He J, Wang K, Liu P, Ren Y (2015) Superiority of minimally invasive oesophagectomy in reducing in-hospital mortality of patients with resectable oesophageal cancer: a meta-analysis. PLoS ONE 10(7):e0132889. https://doi.org/10.1371/journal.pone.0132889
Briez N, Piessen G, Torres F, Lebuffe G, Triboulet JP, Mariette C (2012) Effects of hybrid minimally invasive oesophagectomy on major postoperative pulmonary complications. Br J Surg 99(11):1547–1553. https://doi.org/10.1002/bjs.8931
Petri R, Zuccolo M, Brizzolari M, Rossit L, Rosignoli A, Durastante V, Petrin G, De Cecchis L, Sorrentino M (2012) Minimally invasive esophagectomy: thoracoscopic esophageal mobilization for esophageal cancer with the patient in prone position. Surg Endosc 26(4):1102–1107. https://doi.org/10.1007/s00464-011-2006-5
Yoshida N, Watanabe M, Baba Y, Iwagami S, Ishimoto T, Iwatsuki M, Sakamoto Y, Miyamoto Y, Ozaki N, Baba H (2014) Risk factors for pulmonary complications after esophagectomy for esophageal cancer. Surg Today 44(3):526–532. https://doi.org/10.1007/s00595-013-0577-6
Owen RM, Perez SD, Lytle N, Patel A, Davis SS, Lin E, Sweeney JF (2013) Impact of operative duration on postoperative pulmonary complications in laparoscopic versus open colectomy. Surg Endosc 27(10):3555–3563. https://doi.org/10.1007/s00464-013-2949-9
Dhungel B, Diggs BS, Hunter JG, Sheppard BC, Vetto JT, Dolan JP (2010) Patient and peri-operative predictors of morbidity and mortality after esophagectomy: American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP), 2005–2008. J Gastrointest Surg 14(10):1492–1501. https://doi.org/10.1007/s11605-010-1328-2
Yoshida N, Baba Y, Hiyoshi Y, Shigaki H, Kurashige J, Sakamoto Y, Miyamoto Y, Iwatsuki M, Ishimoto T, Kosumi K, Sugihara H, Harada K, Tokunaga R, Izumi D, Watanabe M, Baba H (2016) Duration of smoking cessation and postoperative morbidity after esophagectomy for esophageal cancer: how long should patients stop smoking before surgery? World J Surg 40(1):142–147. https://doi.org/10.1007/s00268-015-3236-9
Yoshida N, Baba Y, Shigaki H, Harada K, Iwatsuki M, Kurashige J, Sakamoto Y, Miyamoto Y, Ishimoto T, Kosumi K, Tokunaga R, Imamura Y, Ida S, Hiyoshi Y, Watanabe M, Baba H (2016) Preoperative nutritional assessment by controlling nutritional status (CONUT) is useful to estimate postoperative morbidity after esophagectomy for esophageal cancer. World J Surg 40(8):1910–1917. https://doi.org/10.1007/s00268-016-3549-3
Filip B, Scarpa M, Cavallin F, Cagol M, Alfieri R, Saadeh L, Ancona E, Castoro C (2015) Postoperative outcome after oesophagectomy for cancer: nutritional status is the missing ring in the current prognostic scores. Eur J Surg Oncol 41(6):787–794. https://doi.org/10.1016/j.ejso.2015.02.014
Mantziari S, Hubner M, Demartines N, Schafer M (2014) Impact of preoperative risk factors on morbidity after esophagectomy: is there room for improvement? World J Surg 38(11):2882–2890. https://doi.org/10.1007/s00268-014-2686-9
Nozoe T, Kimura Y, Ishida M, Saeki H, Korenaga D, Sugimachi K (2002) Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma. Eur J Surg Oncol 28(4):396–400
Nakamura M, Iwahashi M, Nakamori M, Ishida K, Naka T, Iida T, Katsuda M, Tsuji T, Nakatani Y, Yamaue H (2008) An analysis of the factors contributing to a reduction in the incidence of pulmonary complications following an esophagectomy for esophageal cancer. Langenbeck’s Arch Surg 393(2):127–133. https://doi.org/10.1007/s00423-007-0253-7
Agrelli TF, de Carvalho Ramos M, Guglielminetti R, Silva AA, Crema E (2012) Preoperative ambulatory inspiratory muscle training in patients undergoing esophagectomy. A pilot study. Int Surg 97(3):198–202. https://doi.org/10.9738/cc136.1
Inoue J, Ono R, Makiura D, Kashiwa-Motoyama M, Miura Y, Usami M, Nakamura T, Imanishi T, Kuroda D (2013) Prevention of postoperative pulmonary complications through intensive preoperative respiratory rehabilitation in patients with esophageal cancer. Dis Esophagus 26(1):68–74. https://doi.org/10.1111/j.1442-2050.2012.01336.x
Yamana I, Takeno S, Hashimoto T, Maki K, Shibata R, Shiwaku H, Shimaoka H, Shiota E, Yamashita Y (2015) Randomized controlled study to evaluate the efficacy of a preoperative respiratory rehabilitation program to prevent postoperative pulmonary complications after esophagectomy. Dig Surg 32(5):331–337. https://doi.org/10.1159/000434758
Akutsu Y, Matsubara H, Shuto K, Shiratori T, Uesato M, Miyazawa Y, Hoshino I, Murakami K, Usui A, Kano M, Miyauchi H (2010) Pre-operative dental brushing can reduce the risk of postoperative pneumonia in esophageal cancer patients. Surgery 147(4):497–502. https://doi.org/10.1016/j.surg.2009.10.048
Engelman E, Maeyens C (2010) Effect of preoperative single-dose corticosteroid administration on postoperative morbidity following esophagectomy. J Gastrointest Surg 14(5):788–804. https://doi.org/10.1007/s11605-010-1168-0
Park SY, Lee HS, Jang HJ, Joo J, Zo JI (2012) Efficacy of intraoperative, single-bolus corticosteroid administration to prevent postoperative acute respiratory failure after oesophageal cancer surgery. Interact Cardiovasc Thorac Surg 15(4):639–643. https://doi.org/10.1093/icvts/ivs167
Gao Q, Mok HP, Wang WP, Xiao F, Chen LQ (2014) Effect of perioperative glucocorticoid administration on postoperative complications following esophagectomy: a meta-analysis. Oncol Lett 7(2):349–356. https://doi.org/10.3892/ol.2013.1748
Kawahara Y, Ninomiya I, Fujimura T, Funaki H, Nakagawara H, Takamura H, Oyama K, Tajima H, Fushida S, Inaba H, Kayahara M (2010) Prospective randomized controlled study on the effects of perioperative administration of a neutrophil elastase inhibitor to patients undergoing video-assisted thoracoscopic surgery for thoracic esophageal cancer. Dis Esophagus 23(4):329–339. https://doi.org/10.1111/j.1442-2050.2009.01010.x
Makino H, Kunisaki C, Kosaka T, Akiyama H, Morita S, Endo I (2011) Perioperative use of a neutrophil elastase inhibitor in video-assisted thoracoscopic oesophagectomy for cancer. Brit J Surg 98(7):975–982. https://doi.org/10.1002/bjs.7499
Nagai Y, Watanabe M, Baba Y, Iwatsuki M, Hirashima K, Karashima R, Kurashige J, Kinoshita K, Baba H (2013) Preventive effect of sivelestat on postoperative respiratory disorders after thoracic esophagectomy. Surg Today 43(4):361–366. https://doi.org/10.1007/s00595-013-0508-6
Nishiyama J, Matsuda M, Ando S, Hirasawa M, Suzuki T, Makuuchi H (2012) The effects of the early administration of sivelestat sodium, a selective neutrophil elastase inhibitor, on the postoperative course after radical surgery for esophageal cancer. Surg Today 42(7):659–665. https://doi.org/10.1007/s00595-011-0105-5
Suda K, Kitagawa Y, Ozawa S, Miyasho T, Okamoto M, Saikawa Y, Ueda M, Yamada S, Tasaka S, Funakoshi Y, Hashimoto S, Yokota H, Maruyama I, Ishizaka A, Kitajima M (2007) Neutrophil elastase inhibitor improves postoperative clinical courses after thoracic esophagectomy. Dis Esophagus 20(6):478–486. https://doi.org/10.1111/j.1442-2050.2007.00699.x
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Drs. Uchihara, Yoshida, Baba, Yagi, Toihata, Oda, Kuroda, Eto, Ohuchi, Nakamura, Sawayama, Kinoshita, Iwatsuki, Sakamoto, and Baba have no conflicts of interest or financial ties to disclose.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Uchihara, T., Yoshida, N., Baba, Y. et al. Risk factors for pulmonary morbidities after minimally invasive esophagectomy for esophageal cancer. Surg Endosc 32, 2852–2858 (2018). https://doi.org/10.1007/s00464-017-5993-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-017-5993-z